Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
Article PubMed PubMed Central Google Scholar
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.
Article ADS PubMed PubMed Central Google Scholar
V’kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155–70.
Shanmugam C, Mohammed AR, Ravuri S, Luthra V, Rajagopal N, Karre S. COVID-2019—a comprehensive pathology insight. Pathol Res Pract. 2020;216:153222.
Article PubMed PubMed Central Google Scholar
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92:424–32.
Article PubMed PubMed Central Google Scholar
Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol. 2020;11:1518. https://doi.org/10.3389/fimmu.2020.01518.
Peng X, Gralinski L, Armour CD, Ferris MT, Thomas MJ, Proll S, et al. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. MBio. 2010;1(5):e00206-e210.
Article PubMed PubMed Central Google Scholar
Cheng J, Zhou X, Feng W, Jia M, Zhang X, An T, et al. Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J Cell Mol Med. 2021;25(10):4753–64.
Article PubMed PubMed Central Google Scholar
Chattopadhyay P, Mishra P, Mehta P, Soni J, Gupta R, Tarai B, et al. Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections. Front Immunol. 2022;13:1035111.
Article PubMed PubMed Central Google Scholar
Cheng J, Zhou X, Feng W, Jia M, Zhang X, An T, et al. Risk stratification by long non-coding RNAs profiling in COVID-19. J Cell Mol Med. 2021;25(10):4753–64.
Article PubMed PubMed Central Google Scholar
Ding J, Yin X, Chen J, Zhou J. Current understanding on long non-coding RNAs in immune response to COVID-19. Virus Res. 2022;323:198956.
Article PubMed PubMed Central Google Scholar
Enguita FJ, Leitão AL, McDonald JT, Zaksas V, et al. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. Theranostics. 2022;12(8):3946–62.
Article PubMed PubMed Central Google Scholar
Palmieri G, Paliogiannis P, Sini MC, Manca A, Palomba G, Doneddu V, Tanda F, Pascale MR, Cossu A. Long non-coding RNA CASC2 in human cancer. Crit Rev Oncol Hematol. 2017;111:31–8.
Lu F, Hong Y, Liu L, et al. Long noncoding RNAs: a potential target in sepsis-induced cellular disorder. Exp Cell Res. 2021;406(2):112756.
Zhu L, Shi D, Cao J, Song L. LncRNA CASC2 alleviates sepsis-induced acute lung injury by regulating the miR-152-3p/PDK4 Axis. Immunol Invest. 2021;1–15:1–15.
Fani M, Zandi M, Rezayi M, Khodadad N, Langari H, Amiri I. The role of microRNAs in viral infections. Curr Pharm Des. 2018;24(39):4659–67.
Khan MA, Sany MRU, Islam A, Islam MS. Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 worldwide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19. Front Genet. 2020;11:765.
Article PubMed PubMed Central Google Scholar
Tang T, Bidon M, Jaimes JA, Whittaker GR, Daniel S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antivir Res. 2020;178:104792.
Giannella A, Riccetti S, Sinigaglia A, Piubelli C, Razzaboni E, Di Battista P, Agostini M, Molin ED, Manganelli R, Gobbi F, et al. Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients. Front Immunol. 2022;13:4409.
Fernández-Pato A, Virseda-Berdices A, Resino S, Ryan P, Martínez-González O, Pérez-García F, Martin-Vicente M, Valle-Millares D, Brochado-Kith O, Blancas R, et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg Microbes Infect. 2022;11:676–88.
Article PubMed PubMed Central Google Scholar
Jankovic M, Nikolic D, Novakovic I, Petrovic B, Lackovic M, Santric-Milicevic M. miRNAs as a potential biomarker in the COVID-19 infection and complications course, severity, and outcome. Diagnostics. 2023;13:1091.
Article PubMed PubMed Central Google Scholar
Mohamed HA, Abdelkafy AE, Khairy RMM, et al. MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression. Sci Rep. 2023;13:3531.
Article ADS PubMed PubMed Central Google Scholar
Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, Sonnenschein K, Pink I, Hoeper MM, Welte T, Bauersachs J, David S, Bär C, Thum T. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur J Heart Fail. 2021;23(3):468–75. https://doi.org/10.1002/ejhf.2096.
Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–83.
Simonian M, Sharifi M, Nedaeinia R, Mosallaie M, Khosravi S, Avan A, Ghayour-Mobarhan M, Bagheri H, Salehi R. Evaluation of miR-21 inhibition and its impact on cancer susceptibility candidate 2 long noncoding RNA in the colorectal cancer cell line. Adv Biomed Res. 2018;7:14.
Article PubMed PubMed Central Google Scholar
Feng Y, Zou W, Hu C, Li G, Zhou S, He Y, Ma F, Deng C, Sun L. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. Arch Biochem Biophys. 2017;623–624:20–30.
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020. https://doi.org/10.1148/radiol.2020200230.
Article PubMed PubMed Central Google Scholar
Borghesi A, Zigliani A, Masciullo R, et al. Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients. Radiol Medica. 2020;125(5):461–4. https://doi.org/10.1007/s11547-020-01202-1.
Abo-Hedibah SA, Tharwat N, Elmokadem AH. Is chest X-ray severity scoring for COVID-19 pneumonia reliable? Pol J Radiol. 2021;86:e432–9.
Article PubMed PubMed Central Google Scholar
Shaker OG, Abdelaleem OO, Mahmoud RH, Abdelghaffar NK, Ahmed TI, Said OM, et al. Diagnostic and prognostic role of SerummiR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy. IUBMB Life. 2019;71:310–20.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-DeltaDeltaC(T)) method. Methods. 2001;25:402–8.
Shaker OG, Abdelwahed MY, Ahmed NA, et al. Evaluation of serum long noncoding RNA NEAT and MiR-129–5p in hepatocellular carcinoma. IUBMB Life. 2019;71:1571–8.
Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491–509. https://doi.org/10.1007/s00018-016-2174-5.
Article PubMed PubMed Central Google Scholar
Beermann J, Piccoli M-T, Viereck J, Thum T. Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev. 2016;96(4):1297–325. https://doi.org/10.1152/physrev.00041.2015.
Wang J, Zhang Y, Li Q, Zhao J, Yi D, Ding J, et al. Influenza virus exploits an interferon-independent lncRNA to preserve viral RNA synthesis through stabilizing Viral RNA polymerase PB1. Cell Rep. 2019;27(11):3295-304.e3294. https://doi.org/10.1016/j.celrep.2019.05.036.
Yang Q, Lin F, Wang Y, Zeng M, Luo M. Long noncoding RNAs as emerging regulators of COVID-19. Front Immunol. 2021;12:700184.
Article ADS PubMed PubMed Central Google Scholar
Wang M, Wei J, Shang F, Zang K, Ji T. Long non−coding RNA CASC2 ameliorates sepsis−induced acute kidney injury by regulating the miR −155 and NF−kb pathway. Int J Mol Med. 2020;45:1554–62. https://doi.org/10.3892/ijmm.2020.4518.
Li H, Shi H, Gao M, Ma N, Sun R. Long non-coding RNA CASC2 improved acute lung injury by regulating miR-144-3p/AQP1 axis to reduce lung epithelial cell apoptosis. Cell Biosci. 2018;8:15. https://doi.org/10.1186/s13578-018-0205-7.
留言 (0)